Acurx Pharmaceuticals Inc...
(ACXP)
undefined
undefined%
At close: undefined
0.81
-4.15%
Pre-market Dec 16, 2024, 05:59 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Net Income | -14.58M | -12.09M | -12.75M | -4.60M | -5.93M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 3.77M | 3.30M | 6.74M | 1.27M | 900.43K |
Other Working Capital | 30.02K | 30.35K | -387.84M | -801.17K | 1.05M |
Other Non-Cash Items | 980.75K | 3.30M | 850.26K | 781.70K | 900.43K |
Deferred Income Tax | - | - | - | - | - |
Change in Working Capital | 30.02K | 1.25M | 141.28K | -801.17K | 1.05M |
Operating Cash Flow | -9.80M | -7.54M | -5.01M | -3.35M | -3.99M |
Capital Expenditures | 5.00 | - | - | - | - |
Acquisitions | - | - | - | - | - |
Purchase of Investments | - | - | - | - | - |
Sales Maturities Of Investments | - | - | - | - | - |
Other Investing Acitivies | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Debt Repayment | - | - | - | 66.50K | - |
Common Stock Repurchased | - | - | - | - | - |
Dividend Paid | - | - | - | - | - |
Other Financial Acitivies | 2.22M | 13.00 | - | - | - |
Financial Cash Flow | 8.16M | 3.70M | 14.80M | 4.04M | 4.46M |
Net Cash Flow | -1.64M | -3.85M | 9.78M | 692.09K | 470.17K |
Free Cash Flow | -9.80M | -7.54M | -5.01M | -3.35M | -3.99M |